Travere Therapeutics, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($331.5m) ($376.3m) ($320.6m) ($50.3m) ($67.7m)
Net Income (Loss) Attributable to Parent ($47.9m)
($59.7m) -24.69%
($102.7m) -71.90%
($146.4m) -42.61%
($169.4m) -15.71%
($180.1m) -6.29%
($278.5m) -54.63%
($111.4m) +60.00%
($321.5m) -188.64%
($25.5m) +92.06%
Depreciation, Depletion and Amortization $16.1m $17.8m $18.7m $20.4m $24.6m $26.6m $33.1m $38.5m $43.6m $60.7m $63.4m
Depreciation $16.1m $500k $600k $700k $2.1m $1.7m $2.1m $2.2m $1.8m $1.5m $63.4m
Amortization of Debt Issuance Costs $0 $656k $3.4m $9.9m $10.5m $11.2m $1.6m $1.7m $1.7m $1.6m
Amortization of Intangible Assets $16.0m $17.3m $18.0m $19.7m $22.4m $24.9m $31.0m $36.3m $41.7m $59.2m
Amortization Of Securities ($700k) ($7.5m) ($4.5m) ($4.4m) ($4.4m)
Depreciation Amortization Depletion $20.7m $38.5m $43.6m $60.7m $63.4m
Deferred Income Tax Expense (Benefit) ($22.7m) ($6.4m) $0 $0 $0 $0 $0 $0 $0 $0
Share-based Payment Arrangement, Noncash Expense $29.1m $26.9m $19.8m $21.1m $23.6m $30.8m $39.2m $44.2m $36.9m $44.9m $60.7m
Share-based Payment Arrangement, Expense $29.1m $26.9m $19.8m $21.1m $23.6m $30.8m $39.2m $44.2m $36.9m $44.9m $60.7m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets, Finite-lived $0 $0 $25.5m $0 $0 $0 $0
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss $8k
Nonoperating Income (Expense) $632k ($4.6m) ($21.8m) ($9.1m) ($12.6m) ($17.9m) ($11.6m) $12.0m $3.3m $13.6m
Other Nonoperating Income (Expense) ($264k) $1.1m ($474k) ($314k) $1.4m $231k $974k $1.6m ($3.3m) $11.6m
Changes in operating assets and liabilities:
Change In Working Capital $875k ($25.5m) ($63.0m) ($14.0m) ($1.3m)
Increase (Decrease) in Accounts Receivable $6.1m ($4.9m) ($152k) $5.2m ($2.3m) $59k $682k $11.3m $6.0m $27.8m ($16.1m)
Change In Receivables ($1.4m) ($11.3m) ($6.0m) ($27.0m) ($16.1m)
Changes In Account Receivables ($1.1m) ($11.3m) ($6.0m) ($27.8m) ($16.1m)
Increase (Decrease) in Inventories $306k $1.7m $2.8m $2.0m $5.1m $1.8m $2.1m $39.4m $3.8m ($5.0m) ($2.1m)
Inventory Write-down $2.1m $2.5m $3.0m $2.8m $684k
Change In Inventory ($1.2m) ($39.4m) ($3.8m) $5.0m ($2.1m)
Increase (Decrease) in Accounts Payable ($2.7m) $9.3m ($6.0m) $2.8m $2.3m ($12.1m)
Change In Payables And Accrued Expense $24.2m $47.1m ($48.6m) $28.8m ($12.1m)
Change In Accrued Expense $22.2m $22.3m ($31.1m) $28.8m $46.2m
Change In Other Current Liabilities ($1.6m) ($418k) $5.6m ($9.7m) ($6.3m)
Net Cash Provided by (Used in) Operating Activities ($3.4m)
$7.4m +315.14%
($25.0m) -437.13%
($58.2m) -133.25%
($42.7m) +26.58%
($14.8m) +65.39%
($186.3m) -1159.40%
($280.0m) -50.31%
($237.5m) +15.19%
$37.8m +115.91%
$92.7m +145.34%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.4m $887k $727k $195k $6.8m $5.1m $191k $668k ($101.2m) ($58.2m) ($77.5m)
Gain (Loss) on Disposition of Property Plant Equipment ($62k)
Debt Securities, Realized Gain (Loss) $0
Payments to Acquire Investments $0 ($399.4m)
Payments to Acquire Businesses, Net of Cash Acquired $500k $0 $0 $95.3m $0 $0
Payments for (Proceeds from) Other Investing Activities $600k $0 $40k $404k
Net Other Investing Changes ($791k) ($668k) ($40k) ($404k) ($404k)
Net Cash Provided by (Used in) Investing Activities $10.4m $45.6m ($203.3m) $19.9m ($61.3m) ($137.6m) ($32.6m) $55.8m $99.3m $27.9m ($203.0m)
Cash flows from financing activities:
Repayments of Long-term Debt $40.2m $0 $0 ($419.8m)
Gain (Loss) on Extinguishment of Debt $0 $0 ($17.0m) $0 $0 ($7.6m) $0 $0
Issuance Of Debt $0 $316.2m $0 $0
Long Term Debt Issuance $0 $316.2m $0 $0
Long Term Debt Payments ($211.3m) $0 $0 ($68.9m) ($419.8m)
Net Issuance Payments Of Debt $104.9m $0 $0 ($68.9m) $105.2m
Net Long Term Debt Issuance $104.9m $0 $0 ($68.9m) $105.2m
Repayment Of Debt ($211.3m) $0 $0 ($68.9m) ($419.8m)
Payments for Repurchase of Common Stock $0
Proceeds from Issuance of Common Stock $0 $0 $0 $0 $131.5m $189.3m $20.1m $191.2m $134.7m $0 $0
Common Stock Issuance $19.5m $191.2m $134.7m $0 $0
Issuance Of Capital Stock $19.5m $191.2m $134.7m $0 $0
Proceeds from (Payments for) Other Financing Activities $664k $1.7m $1.8m $2.0m
Net Other Financing Charges ($12.0m) ($2.1m) ($2.1m) ($2.1m) ($18.4m)
Net Cash Provided by (Used in) Financing Activities ($5.7m)
$5.4m +195.63%
$231.9m +4158.27%
($2.1m) -100.90%
$127.7m +6248.92%
$231.7m +81.41%
$117.6m -49.25%
$218.8m +86.06%
$139.4m -36.26%
($33.5m) -124.00%
$153.1m +557.35%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $117k ($58k) ($135k) ($40.4m) $22.3m $81.0m ($104.1m) ($3.5m) $359k $34.5m $117.9m
Beginning Cash Position $165.8m $61.7m $58.2m $58.5m $75.2m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62.4m $84.8m $165.8m $61.7m $58.2m $58.5m $93.0m $117.9m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $117k ($58k) ($135k) ($9k) ($1.3m) $1.7m ($2.8m) $2.0m ($913k) $2.3m ($194k)
Effect Of Exchange Rate Changes ($2.8m) $2.0m ($913k) $2.3m ($194k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $4.0m $8.1m $10.6m $1.6m $3.9m $12.8m $4.6m $3.2m $4.5m $34.7m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.1m $2.1m $1.9m $7.7m $6.9m $7.3m $10.2m $8.8m $8.8m $8.8m
Income Taxes Paid, Net ($3.4m) ($16.4m) $996k $578k $453k
Additional Financial Items
Foreign Currency Transaction Gain (Loss), before Tax $0 $1.1m ($464k) ($112k) $934k ($700k) ($300k)
Foreign Currency Transaction Gain (Loss), Realized $93k ($339k) $39k
Gain (Loss) Related to Litigation Settlement $0 $0
Goodwill $936k $936k $936k $936k $936k $900k $900k $800k $800k
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $37.2m $53.0m ($376.3m) ($320.6m) ($50.3m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $37.2m $53.0m $264.9m ($915k) $24.7m
Income Tax Expense (Benefit) ($9.7m) $1.4m $811k ($21k) ($19.4m) $409k $313k $223k $120k $988k
Interest Expense Nonoperating $11.2m $10.7m
Investment Income, Interest $10.1m $5.0m $2.0m $6.3m $21.8m $17.8m $12.7m
Operating Expenses $191.8m $208.7m $244.3m
Operating Lease, Expense $2.7m $2.0m $4.9m $5.0m $4.9m $4.8m $4.4m
Restructuring Costs $11.4m
Cash Flow From Continuing Financing Activities $120.1m $220.1m $139.4m ($33.5m) $153.1m
Cash Flow From Continuing Investing Activities ($32.6m) ($151.6m) $99.3m $27.9m ($203.0m)
Cash From Discontinued Financing Activities ($2.5m)
($1.4m) +44.25%
$0 +100.00%
$0 $0
Cash From Discontinued Investing Activities $0 $207.4m $0 $0 $0
Change In Account Payable $2.1m $24.8m ($17.6m) ($85k) ($12.1m)
Change In Cash Supplemental As Reported ($104.1m) ($3.5m) $359k $34.5m
Change In Other Working Capital ($13.9m) ($16.8m) ($7.1m) ($3.4m) ($6.2m)
Change In Payable $2.1m $24.8m ($17.6m) ($85k) ($12.1m)
Change In Prepaid Assets ($5.2m) ($4.7m) ($3.2m) ($7.7m) ($10.3m)
Changes In Cash ($101.3m) ($5.5m) $1.3m $32.2m $42.8m
End Cash Position $61.7m $58.2m $58.5m $93.0m $117.9m
Financing Cash Flow $117.6m
$218.8m +86.06%
$139.4m -36.26%
($33.5m) -124.00%
$153.1m +557.35%
Free Cash Flow ($214.7m) ($321.6m) ($338.7m) ($20.4m) $15.2m
Investing Cash Flow ($32.6m) $55.8m $99.3m $27.9m ($203.0m)
Net Intangibles Purchase And Sale ($28.4m) ($41.6m) ($101.2m) ($58.2m) ($77.5m)
Net Investment Purchase And Sale ($3.4m) ($109.4m) $200.6m $86.5m ($125.2m)
Net PPE Purchase And Sale ($5.1m) ($191k) ($668k) ($107k)
Other Non Cash Items $3.0m ($1.9m) $74.9m $183k
Proceeds From Stock Option Exercised $7.6m $31.0m $6.8m $37.5m $66.2m
Provisionand Write Offof Assets $1.0m $3.0m $2.8m $684k $684k
Purchase Of Intangibles ($28.4m) ($41.6m) ($101.2m) ($58.2m) ($77.5m)
Purchase Of Investment ($385.4m) ($443.9m) ($125.8m) ($237.1m) ($399.4m)
Purchase Of PPE ($5.1m) ($191k) ($668k) ($77.5m)
Sale Of Investment $382.0m $334.6m $326.3m $323.6m $274.2m
Stock Based Compensation $38.1m $44.2m $36.9m $44.9m $60.7m